In an outstanding article by Prakash Janakiraman, the symptoms and effects of Alzheimer’s are related to the Endocannabinoid System (ECS).
“The role of the endocannabinoid system (ECS) in neurodegenerative disorders has been demonstrated in recent years. CB1 receptors are widely distributed in brain regions such as the cerebellum, cortex, hippocampus, and basal ganglia. The hippocampus is associated with learning and memory. These areas are often affected in the early course of AD. CB2 is sparsely expressed in the brainstem, cerebellum and microglia.”
There is an explanation of how cannabinoids and terpenoids in cannabis could have therapeutic properties for this debilitating disease.
“It has been shown that plant-derived terpenoids, such as cannabinoids, possess therapeutic potential to effectively treat AD.”
This could mean a positive outcome for patients and loved ones.
“This evidence clearly shows that suppression of excitotoxicity by cannabinoids in addition with neurotrophic benefits could potentially treat AD symptoms.”
Read the complete article here, and see additional research for cannabinoids here. That’s Natural is your pure, potent, and trusted source for CBD-rich hemp oil products with 100% traceability and transparency!
Categories: CBD News